(No. 188) At their new premises at BioPark Regensburg the health fund Techniker Krankenkasse (TK) offers startups a point of contact for various questions on the primary health care market. Furthermore TK promotes innovative products and ideas for the healthcare sector of the future with the Health-i-Initiative.
(No. 187) With the program ESIT (European School for Interdisciplinary Tinnitus Research) the EU is funding with 3.8 million € for a duration of four years the training of emerging researchers in the field of tinnitus research. The Tinitus Centre of the University Regensburg is acting here as coordinator of the twelve European project partners at the Regional Hospital.
(No. 186) For the sixth time BioPark Regensburg together with Patent Attorneys Dehml & Bettehausen are giving out two innovation prizes for application-oriented ideas in science, research and healthcare.
(No. 185) BioPark Regensburg GmbH is launching its new brand "Healthcare Regensburg". In the future all activities within the project Healthcare in Regensburg will be clustered under its registered trademark.
(No. 185) The company located in BioPark Regensburg announced the augmentation of the first tranche of the just recently completed round of financing from 5.2 million € to 7.4 million €. Participating in the augmentation of financing are VRD GmbH, one of the current key investors, "Growth Fund for Bavaria" from Bayern Kapital GmbH and Wolf Biotech GmbH.
(Nr. 184) At BioPark Regensburg a new service provider for potential new drug therapies has gone into operation by the name Firma Assay.Works GmbH. Here the Regensburg enterprise is working closely together with the company Metrion Biosciences Ltd in Cambridge, UK.
(No. 183) „Innovation & Startup Founding“ was discussed as the focus topic during the sixth workshop of the event series for developing a „Health Care Sector Masterplan“ for the region of Regensburg. At the BioPark, stakeholders from both academia and research institutions, as well as from start-up advisory services and economic development, together with experienced company founders have jointly collected content input for this key topic of the masterplan. The finalized masterplan is planned to be released in fall 2017.
(No. 182) The current development of the life science companies in BioRegion Regensburg demonstrates a stable number of companies and employees in East Bavaria. The new business figures presented by BioPark Regensburg GmbH for 2016 are for the Cluster in East Bavaria with 50 companies and 3,872 employees.
(No. 181) In the fifth workshop of the event series for developing a „Health Care Sector Masterplan“ for the region of Regensburg, the content cornerstones for the topics „Location Marketing & Economic Development“ have now been set. In the beginning of 2017 another workshop with the topic of “Innovation & Company Founding” will follow.